NABsys Secures $7,000,000 Series B Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    349 Eddy St Providence, RI 02903
  • Company Description
    NABsys aims to make whole-genome DNA sequencing fast, inexpensive, and accurate enough to be used in clinical care. Our approach builds on existing solid-state technologies to create a whole-genome sequencing technology that employs electronic detection, does not depend on a polymerase, and directly obtains DNA sequence information over hundreds of thousands of bases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funding will be used to accelerate the development and commercialization of the company’s proprietary DNA sequencing platform, which leverages semiconductor technology to achieve the scope and scale required for full integration of genomics into medicine.
  • M&A Terms
  • Venture Investor
    Stata Venture Partners
  • Venture Investor

Trending on Xconomy